1.
Cai W, Zhou D*, Wu W, Tan WL, Wang J, Zhou C, Lou Y*. MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design. 2018 BMC Genomics. 2018 Aug 3;19(1):582. doi: 10.1186/s12864-018-4958-5.（共同通讯, 影响因子 3.7）
2.
Zhou D, Xu L, Huang W, Tonn T. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules. 2018 May 31;23(6).（共同通讯, 影响因子 3.0）